Celularity share price today

(CELU)

Celularity share price is $2.28 & ₹194.25 as on 25 Dec 2024, 2.30 'hrs' IST

$2.28

Market is closed - opens 8 PM, 26 Dec 2024

View live Celularity share price in Dollar and Rupees. Guide to invest in Celularity from India. Also see the sentimental analysis on Indian investors investing in Celularity. Get details on the Indian mutual funds that are investing in Celularity. Get Analyst recommendations and forecasts along with all the Celularity's financials.

Celularity share price movements

Today's Low: $2.25
Today's High: $2.35
$2.28
1.32%
Downside
Day's Volatility :4.08%
Upside
2.8%
52 Weeks Low: $1.30
52 Weeks High: $7.97
$2.28
42.98%
Downside
52 Weeks Volatility :83.69%
Upside
71.39%

Celularity Returns

Period	Celularity Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-24.0%	-9.0%	0.0%
6 Months	-18.57%	-4.6%	0.0%
1 Year	34.59%	3.0%	0.0%
3 Years	-95.45%	0.0%	-21.1%

Celularity Key Statistics

in dollars & INR

Previous Close	$2.28
Open	$2.25
Today's High	$2.3456
Today's Low	$2.25
Market Capitalization	$51.3M
Today's Volume	$83.8K
52 Week High	$7.97
52 Week Low	$1.3
Revenue TTM	$42.7M
EBITDA	$-35.9M
Earnings Per Share (EPS)	$-100.39
Profit Margin	-264.3%
Quarterly Earnings Growth YOY	-0.61%
Return On Equity TTM	-154.23%

How to invest in Celularity from India?

It is very easy for Indian residents to invest directly in Celularity from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Celularity stock in both Indian Rupees (INR) and US Dollars (USD). Search for Celularity or CELU on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Celularity or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Celularity shares which would translate to 0.374 fractional shares of Celularity as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Celularity, in just a few clicks!

Returns in Celularity for Indian investors in Rupees

Investment Value

₹1,00,000

Celularity investment value today

Current value as on today

₹1,37,150

Returns

₹37,150

(+37.15%)

Returns from Celularity Stock

₹34,911 (+34.91%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Celularity

-58%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Celularity on INDmoney from India has reduced in the last 30 days as on Dec 26, 2024. -58% less investors are searching Celularity in the last 30 days versus the previous period.

Global Institutional Holdings in Celularity

Vanguard Group Inc
2.27%
Geode Capital Management, LLC
0.62%
BlackRock Inc
0.41%
HB Wealth Management, LLC
0.16%
Cresset Asset Management, LLC
0.16%
Northern Trust Corp
0.15%

Analyst Recommendation on Celularity

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Celularity(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Celularity

What analysts predicted

Upside of 9.65%

Current:

$2.28

Target:

$2.50

Insights on Celularity

Price Movement
In the last 1 month, CELU stock has moved down by -20.0%
Decreasing Revenue
Revenue is down for the last 3 quarters, 14.68M → 9.29M (in $), with an average decrease of 20.4% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 9.54M → -16.09M (in $), with an average decrease of 268.6% per quarter
CELU vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 120.3%

Celularity Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$21.1M	-
Net Income	$5.9M	-
Net Profit Margin	27.8%	-

	FY20	Y/Y Change
Revenue	$14.3M	↓ 32.48%
Net Income	$-208.2M	↓ 3642.12%
Net Profit Margin	-1.5K%	↓ 1486.22%

	FY21	Y/Y Change
Revenue	$21.3M	↑ 49.43%
Net Income	$-100.1M	↓ 51.92%
Net Profit Margin	-469.27%	↑ 989.15%

	FY22	Y/Y Change
Revenue	$18.0M	↓ 15.75%
Net Income	$14.2M	↓ 114.18%
Net Profit Margin	78.95%	↑ 548.22%

	FY23	Y/Y Change
Revenue	$22.8M	↑ 26.68%
Net Income	$-196.3M	↓ 1483.14%
Net Profit Margin	-862.04%	↓ 940.99%

	Q2 FY23	Q/Q Change
Revenue	$2.9M	↓ 25.34%
Net Income	$-47.9M	↓ 25.1%
Net Profit Margin	-1.6K%	↓ 5.17%

	Q3 FY23	Q/Q Change
Revenue	$3.8M	↑ 28.86%
Net Income	$-93.9M	↑ 95.78%
Net Profit Margin	-2.5K%	↓ 847.53%

	Q4 FY23	Q/Q Change
Revenue	$3.8M	↑ 0.0%
Net Income	$-93.9M	↑ 0.0%
Net Profit Margin	-2.5K%	↑ 0.0%

	Q1 FY24	Q/Q Change
Revenue	$14.7M	↑ 287.77%
Net Income	$-22.0M	↓ 76.55%
Net Profit Margin	-149.94%	↑ 2329.62%

	Q2 FY24	Q/Q Change
Revenue	$12.1M	↓ 17.5%
Net Income	$9.5M	↓ 143.37%
Net Profit Margin	78.82%	↑ 228.76%

	Q3 FY24	Q/Q Change
Revenue	$9.3M	↓ 23.25%
Net Income	$-16.1M	↓ 268.62%
Net Profit Margin	-173.17%	↓ 251.99%

	FY19	Y/Y Change
Profit	$14.8M	-

	FY20	Y/Y Change
Profit	$9.3M	↓ 36.95%

	FY21	Y/Y Change
Profit	$11.7M	↑ 24.99%

	FY22	Y/Y Change
Profit	$-1.7M	↓ 114.47%

	FY23	Y/Y Change
Profit	$6.8M	↓ 499.7%

	Q2 FY23	Q/Q Change
Profit	$1.9M	↓ 108.71%

	Q3 FY23	Q/Q Change
Profit	$184.0K	↓ 90.28%

	Q4 FY23	Q/Q Change
Profit	$184.0K	↑ 0.0%

	Q1 FY24	Q/Q Change
Profit	$13.0M	↑ 6987.5%

	Q2 FY24	Q/Q Change
Profit	$2.5M	↓ 80.81%

	Q3 FY24	Q/Q Change
Profit	$5.4M	↑ 116.26%

	FY18	Y/Y Change
Operating Cash Flow	$-60.0M	-
Investing Cash Flow	$-31.2M	-
Financing Cash Flow	$77.5M	-

	FY19	Y/Y Change
Operating Cash Flow	$-1.1M	↓ 98.17%
Investing Cash Flow	$-31.5M	↑ 0.93%
Financing Cash Flow	$288.8M	↑ 272.46%

	FY20	Y/Y Change
Operating Cash Flow	$-63.2M	↑ 5656.16%
Investing Cash Flow	$578.7K	↓ 101.84%
Financing Cash Flow	$102.0M	↓ 64.68%

	FY21	Y/Y Change
Operating Cash Flow	$-110.1M	↑ 74.22%
Investing Cash Flow	$-5.9M	↓ 1120.04%
Financing Cash Flow	$98.6M	↓ 3.38%

	FY22	Y/Y Change
Operating Cash Flow	$-137.9M	↑ 25.23%
Investing Cash Flow	$-5.2M	↓ 11.3%
Financing Cash Flow	$119.8M	↑ 21.59%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-11.0M	↓ 26.46%
Investing Cash Flow	$-31.0K	↓ 99.03%
Financing Cash Flow	$5.6M	↓ 56.03%

Celularity Technicals Summary

Sell

Neutral

Buy

Celularity is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Celularity Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Celularity Inc	-20.0%	-18.57%	34.59%	-95.45%	-77.51%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Celularity Inc	2.28	NA	NA	0.0	-1.54	-0.15	NA	2.11
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Celularity Inc	Buy	$51.3M	-77.51%	2.28	-264.3%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Celularity

Celularity, Inc. headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified natural killer (NK) cells, genetically-modified NK cells, T-cells engineered with a CAR (CAR T-cells), and mesenchymal-like adherent stromal cells (ASCs) targeting indications across cancer, infectious and degenerative diseases. In addition, Celularity develops and manufactures innovative biomaterials also derived from the postpartum placenta. Celularity believes that by harnessing the placenta’s unique biology and ready availability, it will be able to develop therapeutic solutions that address significant unmet global needs for effective, accessible, and affordable therapies.

Organization	Celularity
Employees	120
CEO	Dr. Robert Joseph Hariri M.D., Ph.D.
Industry	Healthcare

Management People of Celularity

Name	Title
Dr. Robert Joseph Hariri M.D., Ph.D.	Founder, CEO & Chairman
Mr. John R. Haines	Senior EVP, Global Manager & Chief Administrative Officer
Mr. David C. Beers C.F.A.	Chief Financial Officer
Mr. Carlos Ramirez	SVP of Investor Relations

Important FAQs about investing in Celularity from India :

What is Celularity share price today?

Celularity share price today stands at $2.28, Open: $2.25 ; Previous Close: $2.28 ; High: $2.35 ; Low: $2.25 ; 52 Week High: $7.97 ; 52 Week Low: $1.30. The stock opens at $2.25, after a previous close of $2.28. The stock reached a daily high of $2.35 and a low of $2.25, with a 52-week high of $7.97 and a 52-week low of $1.30.

Can Indians buy Celularity shares?

Yes, Indians can invest in the Celularity (CELU) from India.

With INDmoney, you can buy Celularity at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Celularity at zero transaction cost.

How can I buy Celularity shares from India?

It is very easy to buy Celularity from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Celularity be purchased?

Yes, you can buy fractional shares of Celularity with INDmoney app.

What are the documents required to start investing in Celularity stocks?

To start investing in Celularity, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.